U.S. markets closed

Boiron SA (BOI.PA)

Paris - Paris Precio retrasado. Divisa en EUR.
Añadir a la lista de seguimiento
33.75-0.30 (-0.88%)
Al cierre: 05:35PM CEST

Boiron SA

2, avenue de l’Ouest Lyonnais
Messimy 69510
France
33 4 78 45 61 00
https://www.boiron.fr

Sector(es)Healthcare
IndustriaDrug Manufacturers - Specialty & Generic
Empleados a tiempo completo2,813

Ejecutivos clave

NombreTítuloPagarEjecutadoAño de nacimiento
Ms. Valérie Lorentz-PoinsotGM & Executive Director988.23kN/D1969
Mr. Jean-Christophe BayssatDeputy GM, Chief Pharmacist & Director of Pharmaceutical Development411.97kN/D1963
Mr. Eric LambertSecretary General and Chief Financial & Administrative OfficerN/DN/DN/D
Mr. Patrice VarrautDirector of OperationsN/DN/DN/D
Ms. Juliette BaudryHuman Resources DirectorN/DN/DN/D
Fabrice ReyGroup TreasurerN/DN/DN/D
Los importes son a partir de 31 de diciembre de 2022 y los valores de compensación son para el último año fiscal que finaliza en esa fecha. Pago corresponde al salario, las bonificaciones, etc. Ejecutado corresponde al valor de las opciones ejecutadas durante el año fiscal. Divisa en EUR.

Descripción

Boiron SA manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally. The company offers non-proprietary homeopathic medicines and homeopathic specialties; and other healthcare products include medical devices, invitro diagnostics, dietary supplements, cosmetics, and phytotherapy. It also provides homeopathic specialties comprising Oscillococcinum to treat influenza symptoms, such as fever, chills, headaches, and aches; Stodal and Stodaline for treating coughs; Arnigel for adjunctive local treatment of benign trauma in the absence of open wounds; Camilia for the treatment of teething problems for babies; Sédatif PC to treat anxiety and emotional, and minor sleep disorders; Coryzalia for the treatment of cold symptoms and rhinitis; Homéoptic to treat eye discomfort and irritation due to various causes for adults and children; Homéovox for vocal disorders; Homéoplasmine for treating irritated skin and redness; Varésol to treat symptoms of chickenpox; and Arnicare Arthritis for use in the treatment of benign trauma pain. In addition, it offers Dermoplasmine, a plant based multi-use balm that repairs and protects irritated and damaged skin; COVID self-tests and rapid antigenic tests; LABIAMEO, that used to treat outbreaks of localized cold sores; and CONVAMEO to treat physical and mental asthenia. The company offers its products through distribution centers, pharmacies, pharmacy chains, wholesalers, grocery and drugstores, health food stores, and online retail. Boiron SA was founded in 1932 and is headquartered in Messimy, France.

Gestión corporativa

La calificación ISS Governance QuickScore de Boiron SA a partir del 1 de mayo de 2024 es 10. Las puntuaciones principales son Auditoría: 9; Junta: 10; Derechos del accionista: 6; Compensación: 9.

Las puntuaciones de la gestión corporativa son cortesía de Servicios de accionistas institucionales (ISS). Las puntuaciones indican una posición decil en relación con el índice o la región. Una puntuación decil 1 indica que el riesgo de gestión es menor, mientras que una puntuación decil 10 indica que el riesgo de gestión es mayor.